Abstract
World Trade Organization TRIPS Agreement in 1995 has completely altered the international intellectual property system. The harmonization of basic intellectual property standards has operated to protect investment in innovation. But these same harmonized standards had stridently condensed the traditional capacity of suppliers of public goods, such as health care and nutrition, who were catering to the priority needs of developing countries. The paper briefly examines the emergence of TRIPS and the relevant concepts as well as the provisions under the TRIPS pertinent to the access to medicine and the implications of Doha round on public health and access to medicine with special reference to Indian scenario. Through this paper an attempt has been made to critically appraise the controversies surrounding the TRIPS agreement with reference to pharmaceuticals and public health.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
